<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04913714</url>
  </required_header>
  <id_info>
    <org_study_id>OPP1191306</org_study_id>
    <nct_id>NCT04913714</nct_id>
  </id_info>
  <brief_title>10+10+30 Infant Vaccines Communication Via Radio in Ethiopia</brief_title>
  <official_title>10+10+30 Infant Vaccines Communication Via Radio in Ethiopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Syracuse University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Jimma University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas A&amp;M University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bill and Melinda Gates Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Syracuse University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of&#xD;
      drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in&#xD;
      from listeners on childhood vaccination coverage and timeliness&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The evaluation is conducted in 2 districts located in the Oromia region of Ethiopia. One of&#xD;
      the districts will be allocated to receive the 3-month radio intervention while the other&#xD;
      district that will not have access to the radio intervention will serve as the control.&#xD;
&#xD;
      Data collection includes survey of mothers at two &quot;key&quot; times: at baseline (when infants are&#xD;
      at most 5 weeks old; but before beginning the intervention) and at endline (including&#xD;
      examination of infant vaccination records) at most 21 days after the end of the radio&#xD;
      intervention. The same mothers and infants to be followed at endline.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 13, 2020</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Data analyst did not know which group received the intervention</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Penta 3 vaccine coverage of infant</measure>
    <time_frame>up to 3 weeks after the intervention ends</time_frame>
    <description>Infant's vaccination record or mother's recall based on interviewer-administered questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Timeliness of infant vaccines</measure>
    <time_frame>up to 3 weeks after the intervention ends</time_frame>
    <description>Infant's vaccination record or mother's recall based on interviewer-administered questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full coverage of infant vaccines</measure>
    <time_frame>up to 3 weeks after the intervention ends</time_frame>
    <description>Infant's vaccination record or mother's recall based on a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived barriers to vaccination</measure>
    <time_frame>Immediately before intervention starts, and up to 3 weeks after the intervention ends</time_frame>
    <description>Mother completes interviewer-administered questionnaire at specified times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived susceptibility to vaccine-preventable diseases in children</measure>
    <time_frame>Immediately before intervention starts, and up to 3 weeks after the intervention ends</time_frame>
    <description>Mother completes interviewer-administered questionnaire at specified times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived benefits of infant vaccines</measure>
    <time_frame>Immediately before intervention starts, and up to 3 weeks after the intervention ends</time_frame>
    <description>Mother completes interviewer-administered questionnaire at specified times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived severity of vaccine-preventable diseases in children</measure>
    <time_frame>Immediately before intervention starts, and up to 3 weeks after the intervention ends</time_frame>
    <description>Mother completes interviewer-administered questionnaire at specified times</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cues to action</measure>
    <time_frame>Immediately before intervention starts, and up to 3 weeks after the intervention ends</time_frame>
    <description>Mother completes interviewer-administered questionnaire at specified times</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1320</enrollment>
  <condition>Infant ALL</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A district where the radio intervention will be broadcast.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>A district where the radio intervention will not be broadcast.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>3-month radio intervention on infant vaccination</intervention_name>
    <description>Radio intervention comprising 10-minute drama, 10-minute discussion of the drama by trained health extension workers and 30-minute phone-in from listeners</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Mother, with infant of at most 5 weeks old; Lives in the study district; Consents to&#xD;
        participate in study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Mother, with infant of more than 5 weeks old; Does not live in study district; Does not&#xD;
        consent to participate in study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Weeks</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Appiah, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Syracuse University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Syracuse University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13244</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jimma University</name>
      <address>
        <city>Jimma</city>
        <country>Ethiopia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ethiopia</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>June 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data will be shared upon reasonable request after data analysis. Email Dr. Bernard Appiah at beappiah@syr.edu</ipd_description>
    <ipd_time_frame>After publication</ipd_time_frame>
    <ipd_access_criteria>Will be accessible as part of open access publishing</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

